U-Chart Analysis:Immuno-Biological Laboratories Co., Ltd.:4570

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Immuno-Biological Laboratories Co., Ltd. Go to web site 4570 Medicals 東証グロース March 1, 2000 2007.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Immuno-Biological Laboratories Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Immuno-Biological Laboratories Co., Ltd. Balance Sheet 2025年3月期 Immuno-Biological Laboratories Co., Ltd. Balance Sheet 2024年3月期 Immuno-Biological Laboratories Co., Ltd. Balance Sheet 2023年3月期 Immuno-Biological Laboratories Co., Ltd. Balance Sheet 2022年3月期 Immuno-Biological Laboratories Co., Ltd. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents 826 734 614 508 604
Other Current AssetsHelp 565 528 551 621 521
Tangible Fixed AssetsHelp 191 136 119 120 127
Intangible Fixed AssetHelp 0 2 2 2 0
Investments and OthersHelp 264 219 147 453 586
Total AssetsHelp 1,845 1,619 1,434 1,705 1,838
Total Current LiabilitiesHelp 296 269 257 232 150
Total Long-term LiabilitiesHelp 35 85 99 105 59
Shareholder's EquityHelp 1,514 1,265 1,079 1,368 1,629
Total LiabilitiesHelp 1,845 1,619 1,434 1,705 1,838

Immuno-Biological Laboratories Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Immuno-Biological Laboratories Co., Ltd. Profit and Loss Account 2025年3月期 Immuno-Biological Laboratories Co., Ltd. Profit and Loss Account 2024年3月期 Immuno-Biological Laboratories Co., Ltd. Profit and Loss Account 2023年3月期 Immuno-Biological Laboratories Co., Ltd. Profit and Loss Account 2022年3月期 Immuno-Biological Laboratories Co., Ltd. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales 970 817 795 648 603
Total Sales 970 817 795 648 603
Cost of SalesHelp 335 299 268 271 256
Other Costs and RevenueHelp 385 331 816 635 666
Total CostsHelp 720 630 1,084 906 922
Net RevenueHelp 634 517 527 377 347
Earnings Before TaxHelp 210 125 -281 -250 -311
Net IncomeHelp 249 187 -290 -259 -319
Net Income 249 187 -290 -259 -319

Immuno-Biological Laboratories Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Immuno-Biological Laboratories Co., Ltd. Cash Flow Statement 2025年3月期 Immuno-Biological Laboratories Co., Ltd. Cash Flow Statement 2024年3月期 Immuno-Biological Laboratories Co., Ltd. Cash Flow Statement 2023年3月期 Immuno-Biological Laboratories Co., Ltd. Cash Flow Statement 2022年3月期 Immuno-Biological Laboratories Co., Ltd. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help 183 134 80 -93 -194
Investing Cash Flow(ICF)Help -54 -24 30 -156 -17
Financing Cash FlowHelp -32 1 1 144 -216
Exchange Difference of Cash and Cash EquivalentsHelp -2 3 2 2 5
Net Increase and Decrease in Cash and Cash Equivalentsn 96 113 113 -103 -422

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Immuno-Biological Laboratories Co., Ltd.

Company where related level is highHelp

HEALIOS K.K.
MORISHITA JINTAN CO.,LTD.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
SSP CO.,LTD.
ZERIA PHARMACEUTICAL CO.,LTD.
Modalis Therapeutics Corporation
Kidswell Bio Corporation
KAINOS Laboratories,Inc.
Nxera Pharma Co., Ltd.
Fuso Pharmaceutical Industries, Ltd.